GPT Healthcare earnings drag as new Raipur facility losses bite
Revenue grew 15% to ₹478.5 crore, but profits slumped as the company absorbed startup costs at its newest hospital.
What's new
- Q4 revenue rose 24% to ₹128 cr on higher patient volumes.
- Management targets 15% revenue growth and 20.2% EBITDA margins for FY27.
- Raipur hospital should hit monthly breakeven by Q3.
Why it matters
The company's expansion costs are hitting the bottom line now, testing the profitability of new greenfield projects. Future margin stability hinges on successfully scaling these new hospitals while managing insurance delays.
What we're watching
- Whether Raipur hits its monthly breakeven target by Q3.
- Progress on the Jamshedpur facility ahead of its FY27 commissioning.
- Any impact from insurance empanelment delays on realization rates.
The full read
GPT Healthcare closed FY26 with ₹478.5 crore in revenue, a 15% gain, but net profits slipped to ₹42.2 crore. The culprit is the Raipur hospital. It is currently a drag on earnings as it incurs early-stage operational losses.
Salt Lake's flagship performance provided a clear buffer, pushing Q4 revenue up 24% to ₹128 crore on the back of stronger occupancy. Management is optimistic about the year ahead, guiding for 15% top-line growth and EBITDA margins near 20.2%. The path to these targets relies on two distinct factors: the Raipur facility reaching monthly breakeven by the third quarter, and avoiding further friction from insurance empanelment delays. The Jamshedpur site remains a work in progress, with commissioning slated for Q4 FY27. Investors now face a familiar trade-off: paying for growth today through margin compression or waiting for the new footprint to deliver results. They are waiting.